Trade tariffs on Canadian pharmaceuticals expected to increase costs in the US and strain drug supply chains

Up to $3 billion in pharmaceuticals currently used in the United States (U.S.) depend on Canadian manufacturing, according to new research findings from the University of Toronto. Applying 25% trade tariffs to these pharmaceuticals could add $750 million in cost to the U.S. market and has the potential to significantly disrupt drug supply over the long term.